Bausch Health
BHC
237 hedge funds and large institutions have $2.96B invested in Bausch Health in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 71 reducing their positions, and 32 closing their positions.
28% more capital invested
Capital invested by funds: $2.31B → $2.96B (+$645M)
13% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 32
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
1% more funds holding
Funds holding: 234 → 237 (+3)
2% more call options, than puts
Call options by funds: $243M | Put options by funds: $238M
1.37% less ownership
Funds ownership: 79.09% → 77.72% (-1.4%)
31% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$30.5M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$27.2M |
| 3 |
SG Americas Securities
New York
|
+$18.6M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$18.1M |
| 5 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
+$7.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26.1M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$22.4M |
| 3 |
Morgan Stanley
New York
|
-$20M |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$16M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$13.3M |
BHC Hedge Fund Activity: Q1 2024 in Review
237 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2024, worth a combined $2.96B — up 28% from $2.31B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new BHC positions and 32 closed out — a net gain of 4 holders — while 49 added to existing stakes and 71 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $30.5M. The largest seller was Citadel Advisors, cutting an estimated $26.1M.
- 237 institutional investors held Bausch Health (BHC) as of Q1 2024, up from 234 in Q4 2023.
- Funds reported $2.96B of Bausch Health stock for Q1 2024, up 28% quarter-over-quarter.
- 36 funds opened new Bausch Health positions in Q1 2024 and 32 closed out, a net change of +4 holders.
- The largest Bausch Health buyer in Q1 2024 was Arrowstreet Capital, an estimated $30.5M added.
- The largest Bausch Health seller in Q1 2024 was Citadel Advisors, an estimated $26.1M sold.
Based on aggregated 13F filings for Q1 2024.